Vinculin antibody (C-Term)
Quick Overview for Vinculin antibody (C-Term) (ABIN926662)
Target
See all Vinculin (VCL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Purified
-
Immunogen
- VCL antibody was raised in rabbit using the C terminal of VCL as the immunogen
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator.
-
Comment
-
VCL Blocking Peptide, (ABIN5616950), is also available for use as a blocking control in assays to test for specificity of this VCL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Vinculin (VCL)
-
Alternative Name
- VCL
-
Background
- Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. Synonyms: Polyclonal VCL antibody, Anti-VCL antibody, vinculin antibody, CMD1W antibody, CMH15 antibody, MVCL antibody.
-
Pathways
- Cell-Cell Junction Organization, Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-